fluoxetine has been researched along with morphine in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (21.15) | 18.7374 |
| 1990's | 8 (15.38) | 18.2507 |
| 2000's | 15 (28.85) | 29.6817 |
| 2010's | 17 (32.69) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Basbaum, AI; Brown, JL; Matos, FF; Rollema, H | 1 |
| Suh, HH; Tseng, LL | 1 |
| Kleven, MS; Sparber, SB | 1 |
| Izenwasser, S; Kornetsky, C | 2 |
| Goldstein, FJ; Kellstein, DE; Malseed, RT; Ossipov, MH | 1 |
| Flood, JF; Morley, JE | 1 |
| Maickel, RP; Spratto, GR; Tocco, DR | 1 |
| Bemis, KG; Hymson, DL; Hynes, MD; Lochner, MA | 1 |
| Bero, LA; Kuhn, CM | 1 |
| Fuller, RW; Krushinski, JH; Leander, JD; Robertson, DW | 1 |
| Callahan, P; Grandison, L; Rabii, J | 1 |
| Leander, JD; McCleary, P | 1 |
| Gear, RW; Gordon, NC; Heller, PH; Levine, JD | 1 |
| Akunne, HC; Soliman, KF | 1 |
| Etgen, AM; Sokol, J; Vathy, I | 1 |
| Backer, MM; Pick, CG; Schreiber, S | 1 |
| Fletcher, PJ; Sills, TL | 1 |
| Kornetsky, C; Wennemer, HK | 1 |
| Coda, BA; Donaldson, G; Erjavec, MK; Nguyen, Q; Risler, L; Shen, DD | 1 |
| Aston-Jones, G; Harris, GC | 1 |
| Hassanpour, M; Nayebi, AR; Rezazadeh, H | 1 |
| Jain, NK; Kulkarni, SK; Singh, VP | 1 |
| Krsiak, M; Moravec, V; Votava, M | 1 |
| Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E | 1 |
| Cador, M; Koob, GF; Stinus, L; Zorrilla, EP | 1 |
| Dziedzicka-Wasylewska, M; Filip, M; Inan, SY; Przegaliński, E; Wydra, K | 1 |
| Becić, F; Begović, A; Zulić, I | 1 |
| Forray, MI; Gysling, K; Sotomayor, R | 1 |
| Andrade, Ada S; Arthuri, MT; Gameiro, GH; Gameiro, PH; Marcondes, FK; Pereira, LF; Veiga, MC | 1 |
| Kolb, Y; Nicolas, LB; Prinssen, EP | 1 |
| Nakashima, K; Nakashima, MN; Sounvoravong, S; Wada, M | 1 |
| Berger, BD; Raz, S | 1 |
| Alberati, D; Moreau, JL; Mory, R; Pinard, E; Wettstein, JG | 1 |
| Clesse, D; Darcq, E; Goeldner, C; Halter, T; Kieffer, BL; Lutz, PE; Ouagazzal, AM | 1 |
| Altun, A; Bagcivan, I; Durmus, N; Gursoy, S; Ozdemir, E | 1 |
| Martin, WJ; Obedencio, GP; Shen, F; Smith, JA; Tsuruda, PR | 1 |
| Kearney, T; Wu, AH | 1 |
| Fueki, A; Haga, Y; Hayakawa, A; Ikarashi, N; Kon, R; Kusunoki, Y; Machida, Y; Ochiai, W; Sugiyama, K; Tajima, M | 1 |
| Kosiorek-Witek, A; Makulska-Nowak, HE | 1 |
| Barete, S; Consoli, A; Cravero, C; Guinchat, V | 1 |
| Barakat, A; Elbadr, MM; Hamdy, MM | 1 |
| Guo, D; Guo, J; Huang, S; Li, Q; Polli, JE; Shu, Y; Xiong, Z; Ye, Z; Zhang, W; Zhou, H; Zhu, P | 1 |
| Davoudi, S; Dolatshahi, M; Ghorbanzadeh, B; Naserzadeh, R; Paridar, Y | 1 |
1 review(s) available for fluoxetine and morphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fluoxetine and morphine
| Article | Year |
|---|---|
Interactions between fluoxetine and opiate analgesia for postoperative dental pain.
Topics: Adult; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Molar, Third; Morphine; Pain, Postoperative; Pentazocine; Premedication; Tooth Extraction | 1994 |
Morphine-fluoxetine interactions in healthy volunteers: analgesia and side effects.
Topics: Adult; Analgesia; Analgesics, Opioid; Drug Synergism; Fluoxetine; Humans; Morphine; Nausea; Selective Serotonin Reuptake Inhibitors | 2000 |
49 other study(ies) available for fluoxetine and morphine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat.
Topics: Amphetamine; Animals; Dialysis; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Extracellular Space; Fluoxetine; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Morphine; Narcotics; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Serotonin; Spinal Cord; Tetrodotoxin | 1992 |
Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
Topics: Analgesics; Animals; beta-Endorphin; Desipramine; Fluoxetine; Injections, Intraventricular; Injections, Spinal; Leucine; Male; Mice; Mice, Inbred ICR; Morphine; Reaction Time; Thiorphan | 1990 |
Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; 5-Hydroxytryptophan; Animals; Fluoxetine; Male; Methysergide; Mianserin; Morphine; Piperidines; Rats; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1989 |
The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward.
Topics: Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Male; Morphine; Nalidixic Acid; Naphthyridines; Norepinephrine; Rats; Rats, Inbred F344; Reward; Sensory Thresholds | 1989 |
Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines.
Topics: Analgesia; Animals; Antidepressive Agents, Tricyclic; Clomipramine; Desipramine; Drug Interactions; Fluoxetine; Male; Morphine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Opioid; Serotonin; Time Factors | 1988 |
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents | 1987 |
Differential analgetic actions of amphetamine enantiomers in the mouse: a drug-drug interaction study.
Topics: Amphetamine; Analgesics; Animals; Dextroamphetamine; Dopamine; Drug Interactions; Fenclonine; Fluoxetine; Male; Metergoline; Mice; Morphine; Naloxone; Norepinephrine; Pimozide; Serotonin; Stereoisomerism | 1985 |
Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors.
Topics: Animals; Binding, Competitive; Brain; Discrimination, Psychological; Drug Synergism; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Fluoxetine; Male; Morphine; Naloxone; Pain; Propylamines; Rats; Rats, Inbred Strains; Receptors, Opioid; Serotonin | 1985 |
Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Topics: 5-Hydroxytryptophan; Aging; Animals; Animals, Newborn; Corticosterone; Cyproheptadine; Fluoxetine; Growth Hormone; Morphine; p-Chloroamphetamine; Piperazines; Prolactin; Propylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin | 1987 |
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.
Topics: Analgesia; Animals; Brain; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Drinking; Drug Synergism; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Conformation; Morphine; p-Chloroamphetamine; Pain Measurement; Propylamines; Rats; Serotonin; Stereoisomerism; Structure-Activity Relationship | 1988 |
Potentiation of morphine analgesia by D-amphetamine is mediated by norepinephrine and not dopamine.
Topics: Amphetamine; Analgesics; Animals; Dopamine; Dopamine Antagonists; Drug Synergism; Electric Stimulation; Escape Reaction; Fluoxetine; Morphine; Nalidixic Acid; Naphthyridines; Norepinephrine; Pain; Reaction Time; Reticular Formation | 1988 |
Prolactin release and tuberoinfundibular dopaminergic neuronal activity following single and double injections of morphine.
Topics: 5-Hydroxytryptophan; Animals; Dopamine; Fluoxetine; Growth Hormone; Hypothalamus; Injections, Subcutaneous; Male; Morphine; Neurons; Prolactin; Rats; Rats, Inbred Strains | 1986 |
Meperidine-induced hypothermia in the rat.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Drug Interactions; Female; Fluoxetine; Meperidine; Morphine; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Serotonin modulation of pain responsiveness in the aged rat.
Topics: Aging; Animals; Drug Synergism; Fluoxetine; Male; Methysergide; Morphine; Pain; Pain Measurement; Rats; Rats, Inbred F344; Reaction Time; Serotonin | 1994 |
Gender-related differences exist in cortical [3H]nisoxetine binding and are not affected by prenatal morphine exposure.
Topics: Analgesics, Opioid; Animals; Cerebral Cortex; Female; Fluoxetine; Hypothalamus; Kinetics; Male; Morphine; Nerve Endings; Norepinephrine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sex Characteristics | 1997 |
Interactions between different antidepressants and morphine alter gastrointestinal transit in mice.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Gastrointestinal Transit; Male; Mianserin; Mice; Mice, Inbred ICR; Morphine; Naloxone; Narcotic Antagonists; Rats | 1997 |
Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization.
Topics: Analysis of Variance; Animals; Depression, Chemical; Fluoxetine; Male; Morphine; Motor Activity; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors | 1997 |
Fluoxetine blocks expression but not development of sensitization to morphine-induced oral stereotypy in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Dopamine; Fluoxetine; Male; Morphine; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotypic Movement Disorder | 1999 |
Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.
Topics: 5-Hydroxytryptophan; Animals; Anxiety; Conditioning, Psychological; Drug Administration Schedule; Environment, Controlled; Fluoxetine; Head Movements; Male; Morphine; Morphine Dependence; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin; Substance Withdrawal Syndrome | 2001 |
Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats.
Topics: 5,7-Dihydroxytryptamine; Analgesics, Opioid; Animals; Drug Synergism; Fluoxetine; Formaldehyde; Injections, Intraperitoneal; Male; Morphine; Naloxone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Time Factors | 2001 |
On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Hot Temperature; Humans; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Morphine; Pain Measurement; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2001 |
Effects of alprazolam and fluoxetine on morphine sensitization in mice.
Topics: Alprazolam; Animals; Fluoxetine; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Narcotic Antagonists; Narcotics | 2002 |
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Topics: Acamprosate; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Implants; Fluoxetine; Lisuride; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Taurine | 2005 |
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Antidepressive Agents; Biogenic Monoamines; Conditioning, Operant; Cyclohexanols; Cyclopropanes; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Milnacipran; Morphine; Morpholines; Naloxone; Narcotic Antagonists; Nomifensine; Rats; Rats, Wistar; Reboxetine; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Tramadol; Venlafaxine Hydrochloride | 2004 |
Testing of analgesic effect of fluoxetine.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Male; Mice; Morphine; Pain Threshold; Selective Serotonin Reuptake Inhibitors | 2004 |
Acute morphine administration increases extracellular DA levels in the rat lateral septum by decreasing the GABAergic inhibitory tone in the ventral tegmental area.
Topics: Analysis of Variance; Animals; Dopamine; Drug Administration Schedule; Extracellular Fluid; Fluoxetine; gamma-Aminobutyric Acid; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Septum of Brain; Serotonin; Statistics, Nonparametric; Ventral Tegmental Area | 2005 |
Nociception- and anxiety-like behavior in rats submitted to different periods of restraint stress.
Topics: Acute Disease; Adrenocorticotropic Hormone; Analgesics, Opioid; Animals; Anxiety; Chronic Disease; Cortisone; Disease Models, Animal; Emotions; Exploratory Behavior; Fluoxetine; Male; Morphine; Pain; Pain Threshold; Rats; Rats, Wistar; Receptors, Opioid; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Time Factors | 2006 |
A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Haloperidol; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Morphine; Motor Activity; Obsessive-Compulsive Disorder; Pyridines; Reproducibility of Results; Species Specificity; Spiro Compounds | 2006 |
Modification of antiallodynic and antinociceptive effects of morphine by peripheral and central action of fluoxetine in a neuropathic mice model.
Topics: Analgesics; Analysis of Variance; Animals; Drug Therapy, Combination; Fluoxetine; Ligation; Male; Mice; Morphine; Neuralgia; Sciatic Nerve; Selective Serotonin Reuptake Inhibitors | 2007 |
Effects of fluoxetine and PCPA on isolation-induced morphine self-administration and startle reactivity.
Topics: Animals; Fenclonine; Fluoxetine; Male; Morphine; Random Allocation; Rats; Rats, Wistar; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Self Administration; Social Isolation | 2010 |
Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential.
Topics: Aminoquinolines; Animals; Antipsychotic Agents; Binding Sites; Binding, Competitive; Brain Chemistry; Cell Line; Cricetinae; Cricetulus; DNA, Complementary; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Glycine; Glycine Agents; Glycine Plasma Membrane Transport Proteins; Humans; Male; Membranes; Mice; Morphine; Motor Activity; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors | 2010 |
Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Disease Models, Animal; Drug Evaluation, Preclinical; Emotions; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Prosencephalon; Raphe Nuclei; Serotonin; Social Behavior; Substance Withdrawal Syndrome; Time Factors | 2011 |
Effects of fluoxetine and LY 367265 on tolerance to the analgesic effect of morphine in rats.
Topics: Analgesics, Opioid; Animals; Cyclic S-Oxides; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Fluoxetine; Hot Temperature; Male; Models, Animal; Morphine; Pain Threshold; Rats; Rats, Wistar; Serotonin Antagonists; Thiadiazoles; Time Factors | 2011 |
Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Topics: Analgesia; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Chromatography, Liquid; Drug Synergism; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Morphine; Morpholines; Neurotransmitter Uptake Inhibitors; Nociceptive Pain; Norepinephrine Plasma Membrane Transport Proteins; Ondansetron; Propylamines; Rats; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins; Tandem Mass Spectrometry; Thiophenes | 2013 |
Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics.
Topics: Accidents, Traffic; Analgesics, Opioid; Bupropion; Codeine; Cytochrome P-450 CYP2D6; Dopamine Uptake Inhibitors; Female; Fluoxetine; Forensic Toxicology; Genetic Carrier Screening; Genotype; Glucuronosyltransferase; Humans; Migraine Disorders; Morphine; Pharmacogenetics; Phenotype; Selective Serotonin Reuptake Inhibitors | 2013 |
Morphine-Induced Constipation Develops With Increased Aquaporin-3 Expression in the Colon via Increased Serotonin Secretion.
Topics: Analgesics, Opioid; Animals; Aquaporin 3; Colon; Constipation; Defecation; Disease Models, Animal; Fluoxetine; HT29 Cells; Humans; Male; Mercuric Chloride; Morphine; PPAR gamma; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Up-Regulation; Water | 2015 |
Morphine Analgesia Modification in Normotensive and Hypertensive Female Rats after Repeated Fluoxetine Administration.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Estrous Cycle; Female; Fluoxetine; Hypertension; Male; Morphine; Pain Threshold; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Species Specificity | 2016 |
Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.
Topics: Adult; Anemia, Iron-Deficiency; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Comorbidity; De Lange Syndrome; Depression; Ehlers-Danlos Syndrome; Fluoxetine; Follow-Up Studies; Hospitalization; Humans; Male; Massage; Morphine; Pain; Pain Management; Problem Behavior; Self Mutilation; Treatment Outcome | 2016 |
Fluoxetine uses in nociceptive pain management: a promising adjuvant to opioid analgesics.
Topics: Analgesics, Opioid; Animals; Drug Synergism; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Morphine; Nociceptive Pain; Pain Measurement; Pain Threshold; Selective Serotonin Reuptake Inhibitors | 2018 |
Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Topics: Amitriptyline; Animals; Drug Interactions; Fluoxetine; HEK293 Cells; Humans; Imipramine; Irinotecan; Mice, Inbred C57BL; Morphine; Narcotics; Ondansetron; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Tissue Distribution; Verapamil | 2018 |
Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of simvastatin in mice: Without tolerance and withdrawal syndrome.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Depression; Drug Tolerance; Fluoxetine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Locomotion; Mice; Morphine; Naloxone; Narcotic Antagonists; Open Field Test; Receptors, Opioid; Simvastatin; Substance Withdrawal Syndrome; Swimming | 2020 |